Cargando…
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells
BACKGROUND: Hepcidin, a key regulator of iron metabolism, is produced mainly by interleukin-6 (IL-6) during inflammation. A mechanism linking cancer-related anemia and IL-6 through hepcidin production is suggested. To clarify the hypothesis that overproduction of IL-6 elevates hepcidin levels and co...
Autores principales: | Noguchi-Sasaki, Mariko, Sasaki, Yusuke, Shimonaka, Yasushi, Mori, Kazushige, Fujimoto-Ouchi, Kaori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828826/ https://www.ncbi.nlm.nih.gov/pubmed/27068103 http://dx.doi.org/10.1186/s12885-016-2305-2 |
Ejemplares similares
-
Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients
por: Ibricevic-Balic, Lejla, et al.
Publicado: (2016) -
Aplastic anemia severity and IL-6 and IL-8 blood levels
por: Bhargawa, Sharvan Kumar, et al.
Publicado: (2022) -
High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy
por: Agus Somia, I Ketut, et al.
Publicado: (2019) -
IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm
por: Kamińska, Joanna, et al.
Publicado: (2021) -
S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway
por: Wang, Minjun, et al.
Publicado: (2016)